https://www.healio.com/news/endocrinology/20231018/dual-glp1gip-agonist-shows-promising-impact-on-liver-fat-lipids-on-top-of-weight-loss
DALLAS — New data presented at ObesityWeek demonstrate an encouraging early profile of an investigational dual GLP-1/GIP receptor agonist in healthy adults, according to a speaker at ObesityWeek.VK2735 (Viking Therapeutics) is a novel dual agonist of th…
Create an account
or login to join the discussion